Every material Form 8-K Blue Bird Corp has filed with the SEC since August 05, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Blue Bird Corporation entered into a Second Amendment to its Credit Agreement, raising total committed facilities to $600 million from $250 million and extending maturity to September 30, 2031. Pricing falls to SOFR plus 1.25% to 2.25%, based on leverage, from SOFR plus 1.75% to 3.25%, and the new delayed draw term loan can fund capital projects, research and development, working capital, or refinance existing debt. The maximum total net leverage ratio rises to 3.25x, and the company also closed a separate Canadian dollar line for its Micro Bird unit.
Total facilities rise to $600 million from $250 million, including a $300 million revolver (up from $150 million) and a $300 million delayed draw term loan
Maturity extended from November 17, 2028 to September 30, 2031
Margin lowered to SOFR plus 1.25% to 2.25% from SOFR plus 1.75% to 3.25%; 0.10% credit spread adjustment eliminated
At closing, about $86 million was carried over as drawn debt, with $214 million available to draw under the Borrower's facilities and $670+ million of liquidity per the press release
Blue Bird filed a prospectus supplement to its existing shelf registration covering the resale of up to 2,702,180 common shares by a selling stockholder. The shares would be issued if the holder exchanges non-voting exchangeable shares of a Canadian subsidiary, tied to the April 1, 2026 acquisition of the Micro Bird joint venture's 50% interest. The 8-K itself was filed to attach a legal opinion on the validity of the shares.
Up to 2,702,180 shares of common stock may be resold by the selling stockholder
Shares are issuable on exchange, retraction or redemption of non-voting exchangeable shares of MB Exchangeco Inc.
Exchangeable shares were issued in connection with the April 1, 2026 acquisition of the 50% Micro Bird joint venture interest
Blue Bird reported fiscal 2026 third-quarter net sales of $517.2 million, up 29.9% from a year earlier, and GAAP net income of $185.3 million, which includes a $160.5 million non-cash gain from remeasuring its prior 50% stake in Micro Bird. The company raised its full-year 2026 Adjusted EBITDA guidance to about $247 million and net revenue guidance to about $1.75 billion, and said it expects to reach Adjusted EBITDA of $500 million or more by 2030 or later, alongside a Ford collaboration and a planned purchase of Detroit Chassis assets expected to close in early 2027.
Q3 diluted EPS was $5.27 versus $1.12 a year earlier; nine-month diluted EPS was $7.33 versus $2.76
Q3 Adjusted EBITDA was $71.4 million, with Micro Bird contributing $16.5 million
Legacy Blue Bird Q3 net sales fell $3.8 million, or 1.0%, partly due to timing of units to be recognized in Q4
FY2026 guidance: net revenue of about $1.75 billion and Adjusted EBITDA of about $247 million
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Blue Bird Corp filing is on SEC EDGAR ↗. 8-K briefs of other companies →